fda compounding semaglutide warning september 2025 Drug Recalls and Warnings: Recalls for Compounded and Tirzepatide, Wegovy; Facility Letters September 2, 2025: U.S. compounding

Nevertheless, understanding GI adverse events across both earlier and newer GLP-1based therapies remains highly relevant, particularly as these agents are increasingly prescribed for long-term and off-label indications

Vitamin B12 absorption depends on a multi-step process that starts in the stomach

Not for human administration, clinical diagnosis, medical treatment or animal therapeutic application

I think it's vital to stay informed and consider how tools like this can empower us on our individual health journeys for a healthier, happier life.

Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M (2023) Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss

Retatrutide generally improves cardiovascular markers through weight loss